Is Mounjaro Used for Diabetes?

Tirzepatide, the active substance in Mounjaro, was first studied and approved for use in adults with type 2 diabetes. It works by activating two hormone receptors — GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) — that play roles in blood sugar regulation and appetite control. This dual mechanism is what sets tirzepatide apart from medicines that act on GLP-1 alone.

Because the same pathways that help regulate blood glucose also influence appetite and feelings of fullness, tirzepatide was subsequently studied for weight management in people without diabetes. It is now licensed for both indications in a number of countries, though the specific prescribing criteria differ between them — always a decision for your prescriber or doctor.

How does this compare to Wegovy?

Wegovy (semaglutide) follows a similar story: its active substance, semaglutide, was first used in a diabetes medicine before a higher-dose formulation was licensed specifically for weight management. Semaglutide acts on GLP-1 receptors only, making it a single-agonist medicine compared with tirzepatide's dual action. You can read more on the overview of what Wegovy is and how it is used.

Weight loss injections and diabetes — what is the link?

The connection between injections used for weight loss and diabetes treatment reflects how closely blood sugar control and body weight are related for many people. GLP-1 receptor agonists were developed within diabetes medicine, and the weight-management applications emerged from that research. For a broader look at how tirzepatide works in the body, see the full explanation of Mounjaro's mechanism.

For a general introduction to the medicine itself, the pages on what Mounjaro is and the basics of Mounjaro cover the essentials. There is also a dedicated page exploring Mounjaro's role in diabetes treatment specifically if you want more detail on that aspect.

According to information published on the electronic Medicines Compendium (eMC), tirzepatide is a prescription-only medicine and its licensed indications are described in the official Summary of Product Characteristics.

Whether you have been prescribed Mounjaro for weight management, for type 2 diabetes, or both, keeping a clear record of your journey matters. GLP Trackr's daily check-in and insights features let you log how you feel each day — energy levels, mood, sleep, and any side effects — so you can build up a picture of how the medicine is sitting with you over time.

The app's dose and injection logging means every weekly shot is recorded with its date, strength, and site, giving you an accurate history to refer back to or share with your prescriber at your next appointment. The doctor report feature lets you bring a clear summary of your tracked data to any consultation — useful context whether you are being monitored for blood sugar, weight, or both.

GLP Trackr is a tracking companion, not a clinical tool — it does not interpret your results or offer medical guidance. Any questions about how Mounjaro is affecting your health, your blood glucose, or your dose should always go to your prescriber or doctor, who knows your full medical history.

If you are tracking side effects or noticing changes in how you feel, log them in the app and bring the record to your next appointment. If anything feels severe, persistent, or worrying, contact your healthcare professional promptly rather than waiting.

Ready to keep every part of your journey in one place? GLP Trackr is available free on the App Store and Google Play — start a 7-day free trial and see how it fits your routine.